MX2007009501A - Inhibidores de formacion de fibrillas amiloides de transtiretina. - Google Patents

Inhibidores de formacion de fibrillas amiloides de transtiretina.

Info

Publication number
MX2007009501A
MX2007009501A MX2007009501A MX2007009501A MX2007009501A MX 2007009501 A MX2007009501 A MX 2007009501A MX 2007009501 A MX2007009501 A MX 2007009501A MX 2007009501 A MX2007009501 A MX 2007009501A MX 2007009501 A MX2007009501 A MX 2007009501A
Authority
MX
Mexico
Prior art keywords
inhibitors
fibril formation
amyloid fibril
transthyretin amyloid
transthyretin
Prior art date
Application number
MX2007009501A
Other languages
English (en)
Inventor
Jeffery W Kelly
Steven M Johnson
Michael H Petrassi
Original Assignee
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Inst filed Critical Scripps Research Inst
Publication of MX2007009501A publication Critical patent/MX2007009501A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C245/00—Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond
    • C07C245/02—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides
    • C07C245/06—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings
    • C07C245/08—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings with the two nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings, e.g. azobenzene
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/50—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals
    • C07C251/60—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals of hydrocarbon radicals substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C249/02—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of compounds containing imino groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/50—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/50—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals
    • C07C251/52—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals of hydrocarbon radicals substituted by halogen atoms or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/50—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals
    • C07C251/56—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals of hydrocarbon radicals substituted by doubly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/72—Hydrazones
    • C07C251/86—Hydrazones having doubly-bound carbon atoms of hydrazone groups bound to carbon atoms of six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Bisariloxima eteres y bisarilhidrazonas se muestran siendo efectivos para inhibir la formacion de fibrillas amiloides de transtiretina.
MX2007009501A 2005-02-08 2006-02-08 Inhibidores de formacion de fibrillas amiloides de transtiretina. MX2007009501A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65130605P 2005-02-08 2005-02-08
PCT/US2006/004512 WO2006086517A2 (en) 2005-02-08 2006-02-08 Inhibitors of transthyretin amyloid fibril formation

Publications (1)

Publication Number Publication Date
MX2007009501A true MX2007009501A (es) 2008-02-12

Family

ID=36793700

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007009501A MX2007009501A (es) 2005-02-08 2006-02-08 Inhibidores de formacion de fibrillas amiloides de transtiretina.

Country Status (12)

Country Link
US (2) US20090054629A1 (es)
EP (1) EP1848688A2 (es)
JP (1) JP2008530104A (es)
KR (1) KR20070101386A (es)
CN (1) CN101115712A (es)
AU (1) AU2006213829A1 (es)
BR (1) BRPI0606812A2 (es)
CA (1) CA2596646A1 (es)
IL (1) IL184799A0 (es)
MX (1) MX2007009501A (es)
RU (1) RU2007125278A (es)
WO (1) WO2006086517A2 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009530401A (ja) * 2006-03-24 2009-08-27 ザ・フェインスタイン・インスティチュート・フォー・メディカル・リサーチ フェノールヒドラゾンマクロファージ転移阻害因子阻害剤
US20080119491A1 (en) * 2006-09-19 2008-05-22 Incyte Corporation Amidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
JP5196448B2 (ja) * 2007-12-21 2013-05-15 独立行政法人産業技術総合研究所 アミノオキシ基を含有する反応性化合物
US20100190832A1 (en) * 2008-10-17 2010-07-29 National Institute Of Immunology. Mechanism-based inhibitors of transthyretin amyloidosis: studies with biphenyl ethers and structural templates
CN102844290B (zh) 2010-04-21 2015-06-17 奇斯药制品公司 用于治疗转甲状腺素蛋白淀粉样变性的1-(2-氟联苯-4-基)-烷基羧酸衍生物
US20140309172A1 (en) 2010-11-05 2014-10-16 Dagmar Ringe Ice inhibiting compounds and uses thereof
WO2016080853A1 (en) 2014-11-21 2016-05-26 Bsim2 – Biomolecular Simulations Lda 2-thioxothiazolidin-4-one derivatives active as transthyretin ligands and uses thereof
WO2018053587A1 (en) * 2016-09-21 2018-03-29 Vectus Biosystems Limited Compositions for the treatment of hypertension and/or fibrosis
WO2018237296A1 (en) * 2017-06-23 2018-12-27 City Of Hope PARG INHIBITORS AND METHOD OF USE THEREOF
US20240139214A1 (en) * 2021-02-04 2024-05-02 Kyushu University, National University Corporation Agent for suppressing il-31 production and pharmaceutical composition containing the same
CN114014779A (zh) * 2021-12-14 2022-02-08 安徽师范大学 一种双芳基肟醚化合物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4270947A (en) * 1979-07-02 1981-06-02 Stauffer Chemical Company α-(Phenylazo)-2,6-dichlorobenzaldimino esters and their use as herbicides
AU2002953533A0 (en) * 2002-12-24 2003-01-16 Arthron Limited Fc receptor modulating compounds and compositions

Also Published As

Publication number Publication date
AU2006213829A1 (en) 2006-08-17
US7312361B2 (en) 2007-12-25
US20060178527A1 (en) 2006-08-10
RU2007125278A (ru) 2009-03-20
CA2596646A1 (en) 2006-08-17
JP2008530104A (ja) 2008-08-07
WO2006086517A2 (en) 2006-08-17
IL184799A0 (en) 2007-12-03
US20090054629A1 (en) 2009-02-26
WO2006086517A3 (en) 2006-11-16
EP1848688A2 (en) 2007-10-31
CN101115712A (zh) 2008-01-30
BRPI0606812A2 (pt) 2009-07-14
KR20070101386A (ko) 2007-10-16

Similar Documents

Publication Publication Date Title
MX2007009501A (es) Inhibidores de formacion de fibrillas amiloides de transtiretina.
MX2010009765A (es) Moleculas pequeñas que contienen boro como agentes anti-inflamatorios.
MX2010010209A (es) 4-hidroxipirimidina-5-carboxamidas sustituidas.
TW200640924A (en) VEGF-R2 inhibitors and methods
MX353257B (es) Compuestos heterociclicos utiles como inhibidores de proteina cinasa-1 dependiente de 3-fosfoinositido (pdk1).
MY165728A (en) Selective glycosidase inhibitors and uses thereof
BR112012000934A2 (pt) cassetes e métodos de utilizacao destes
MY171289A (en) Inhibitors of e1 activating enzymes
EA201170212A1 (ru) Охлаждение и обработка материалов
EA200900441A1 (ru) Способы и интермедиаты для получения ингибиторов интегразы
EA201170288A1 (ru) Оксабициклогептаны и оксабициклогептены, их получение и применение
MA32551B1 (fr) Nouveaux composes utiles pour le traitement de maladies degeneratives et inflammatoires
JO2788B1 (en) Amido phenoxyendazole compounds beneficial as C-MET inhibitors
BR112012009576A2 (pt) potencializador alostérico de mglur4, composições, e métodos de tratamento de disfunção neurológica
EA201101686A1 (ru) Новые композиции для лечения шмт и связанных с ней расстройств
MX2009010960A (es) Compuestos heterociclicos y sus metodos de uso.
MX2009005725A (es) Metodos y composiciones para tratamiento y monitoreo de tratamiento de trastornos asociados con il-13.
MX2010002734A (es) Derivados de 1-amino-alquilciclohexano para el tratamiento y prevencion de perdida auditiva.
MX2008011872A (es) Analogos de tiazolidinediona para el tratamiento de la hipertension y para disminuir lipidos.
MX2009013982A (es) Composiciones que comprenden inhibidores de triptofano hidroxilasa.
MX2009010701A (es) Metodos para inhibir la union de endosialina a ligandos.
MX2011013878A (es) 4-hidroxipirimidina-5-carboxamidas sustituidas.
HK1129275A1 (en) Treatment of inflammatory disorders with triazole compounds
MA32474B1 (fr) Nouveaux derives de (piperazinyl ponte) -1-alcanone et leur utilisation comme inhibiteurs de p75
MX2011013324A (es) Uso de derivados de oxindol sustituidos para el tratamiento y profilaxis del dolor.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal